Related Experiment Video
Updated: Jun 29, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
[Gorham-stout disease]
1Orthopädische Klinik, Universitätsklinikum Leipzig. eckehard.schumann@uniklinik-leipzig.de
Zeitschrift Fur Orthopadie Und Unfallchirurgie
|October 11, 2008
Summary
Gorham-Stout disease, a rare condition causing massive bone loss, can affect the spine. Treatment with bisphosphonates and radiation achieved remission in a lumbar spine case, showing disease progression can be limited.
Area of Science:
- Orthopedics
- Radiology
- Oncology
Background:
- Gorham-Stout disease is a rare, aggressive condition characterized by massive osteolysis (bone loss).
- Pathogenesis theories include hemangiomatosis and osteoclast overstimulation, leading to progressive skeletal destruction.
- The disease can involve adjacent soft tissues, complicating management.
Observation:
- A 45-year-old male presented with an osteolytic lesion in the 4th lumbar vertebra after trauma.
- Radiological investigations excluded malignancy and suggested Gorham-Stout disease.
- The lesion showed depression in the ventral roof plate of the vertebra.
Findings:
- Treatment involved bisphosphonates and fractionated radiation therapy (30 Gy) to the affected vertebra.
- A remission of the osteolytic lesion was achieved.
- The patient experienced no complications during treatment.
Implications:
- Spinal involvement in Gorham-Stout disease is rare but carries risks of neurological complications and high mortality.
- Combined therapy of radiation and antiresorptive agents can limit destructive progression.
- While a causal therapy remains unknown, current treatments offer hope for managing this rare condition.
Related Concept Videos
01:25Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...